Researchers discover a potential target for therapy for patients with a deadly prostate cancer
Monday, November 8, 2010 - 09:30
in Health & Medicine
A monoclonal antibody targeting a well known cell surface protein inhibited prostate cancer growth and metastasis in an aggressive form of the disease that did not respond to hormone therapy, according to a study by researchers with the UCLA Department of Urology and UCLA's Jonsson Comprehensive Cancer Center.